DUSA Pharmaceuticals, Inc. to Hold Conference Call Announcing Q1 2002 Corporate Highlights and Financial Results.Business Editors/Health & Medical Writers WILMINGTON, Mass.--(BUSINESS WIRE)--May 8, 2002 DUSA DUSA Deputy Under Secretary of the Army DUSA Deakin University Student Association DUSA Dundee University Students' Association (Scotland) DUSA Designated Unclassified Subject Area Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on NMS See NetWare Management System. : DUSA) announces that its Q1 2002 corporate highlights and financial results press release will be issued on Tuesday, May 14th at 8:00 a.m., to be followed by a conference call at 8:45 a.m.
Tuesday, May 14th, 2002, at 8:45 a.m. Eastern
If calling from the US or Canada dial the following toll-free
number:
877.461.2816
For International and Toronto callers, dial 416.695.6120
You will also be able to listen to a replay of the conference call
until May 21st by dialing the following numbers:
North American callers 888.509.0081
Toronto & International callers 416.695.9728
The call will be accessible on our web site after Tuesday, May 14th at www.dusapharma.com. DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of Levulan(R) Photodynamic Therapy photodynamic therapy n. A type of phototherapy in which a nontoxic light-sensitive compound that has been injected into a patient is exposed selectively to light, whereupon it becomes toxic to targeted malignant and other diseased cells. (PDT PDT abbr. Pacific Daylight Time PDT Pacific Daylight Time PDT n abbr (US) (= Pacific Daylight Time) → hora de verano del Pacífico PDT ) and Photodetection (PD) for multiple medical indications. PDT and PD utilize light-activated compounds such as Levulan(R) to induce a therapeutic or detection effect. DUSA is a world leader in topically or locally applied PDT and PD. The Company maintains offices in Wilmington, MA, Valhalla, NY, and Toronto, Ontario. For further information contact: D. Geoffrey Shulman, MD, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. or Shari Lovell, Director, Shareholder Services Tel: 416.363.5059 Fax 416.363.6602 or visit www.dusapharma.com |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion